Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck inventories — Raw Materials and Work in Process ($M) ($M)
Form 10-Q / 10-K Note 7 Inventories
Latest, Q2 2026
11,194
Period ended Jun 30, 2026
Change on a year earlier
+13.2%
9,888 in Q2 2025
History
12 quarters
Since Q4 2022
Sources
11
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories — Raw Materials and Work in Process ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 11,194 | +13.2% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 11,136 | +21.3% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 10,645 | +20.5% | Form 10-Q (filed 2026-08-07) ↗ |
| Q3 2025 | Sep 30, 2025 | 10,165 | +15.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 9,888 | +16.9% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 9,179 | +9.7% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 8,831 | +9.9% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2024 | Sep 30, 2024 | 8,780 | – | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 8,456 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 8,366 | – | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 8,037 | +13.8% | Form 10-K (filed 2025-02-25) ↗ |
| Q4 2022 | Dec 31, 2022 | 7,063 | – | Form 10-K (filed 2024-02-26) ↗ |
Cite this data
StockData. (2026). Merck Inventories — Raw Materials and Work in Process ($M) ($M), quarterly Q4 2022–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/inv_stage_wip_raw
See every metric in the Merck KPI table. Data updated Oct 26, 2026.